Related Experiment Video

Updated: Aug 22, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

[Regulation of EGF-receptor expression by TGFalpha in human prostate androgen-unresponsive cancer cells]

Weiguo Chen1, Chunyin Yan, Jinxian Pu

  • 1Department of Urology, the First Affiliated Hospital of Suzhou University, Suzhou, Jiangsu 215006, China. wg.chen@sohu.com

Zhonghua Nan Ke Xue = National Journal of Andrology
|September 15, 2004
PubMed
Abstract

Insights

Transforming growth factor-alpha (TGFalpha) significantly increases epidermal growth factor receptor (EGFR) mRNA and protein in androgen-unresponsive prostate cancer cells. This suggests TGFalpha, not EGF, drives an autocrine loop crucial for prostate cancer growth.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Prostate cancer growth is influenced by growth factors.
  • Androgen-unresponsive prostate cancer presents therapeutic challenges.
  • Epidermal growth factor receptor (EGFR) signaling is implicated in cancer progression.

Purpose of the Study:

  • To investigate the role of transforming growth factor-alpha (TGFalpha) and epidermal growth factor (EGF) in regulating EGFR expression.
  • To understand the mechanisms of EGFR regulation in human prostate cancer androgen-unresponsive cell lines.

Main Methods:

  • Utilized reverse transcription-polymerase chain reaction (RT-PCR) to quantify EGFR mRNA levels.
  • Employed Western blot analysis to measure EGFR protein expression.
  • Treated androgen-unresponsive prostate cancer cell lines (ARCaP and PC3) with exogenous TGFalpha.

Main Results:

  • TGFalpha treatment significantly upregulated EGFR mRNA in both PC3 and ARCaP cells.
  • EGFR protein levels increased in PC3 cells following TGFalpha exposure.
  • EGFR protein levels in ARCaP cells showed no significant change after TGFalpha treatment compared to controls.

Conclusions:

  • The TGFalpha/EGF-EGFR signaling pathway is a critical regulator of growth in prostate cancer.
  • TGFalpha, distinct from EGF, appears to maintain an autocrine loop in androgen-unresponsive prostate cancer.
  • These findings highlight TGFalpha as a potential therapeutic target in advanced prostate cancer.

More Related Videos

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...